[1]袁红莲.乳酸菌阴道胶囊联合甲硝唑片对阴道炎患者阴道乳酸菌恢复及复发的影响[J].医学信息,2023,36(13):138-140.[doi:10.3969/j.issn.1006-1959.2023.13.029]
 YUAN Hong-lian.Effect of Lactobacillus Vaginal Capsule Combined with Metronidazole Tablets on the Recovery and Recurrence of vaginal Lactobacillus in Patients with Vaginitis[J].Journal of Medical Information,2023,36(13):138-140.[doi:10.3969/j.issn.1006-1959.2023.13.029]
点击复制

乳酸菌阴道胶囊联合甲硝唑片对阴道炎患者阴道乳酸菌恢复及复发的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年13期
页码:
138-140
栏目:
论著
出版日期:
2023-07-01

文章信息/Info

Title:
Effect of Lactobacillus Vaginal Capsule Combined with Metronidazole Tablets on the Recovery and Recurrence of vaginal Lactobacillus in Patients with Vaginitis
文章编号:
1006-1959(2023)13-0138-03
作者:
袁红莲
(安义县妇幼保健计划生育服务中心,江西 安义 330500)
Author(s):
YUAN Hong-lian
(Anyi County Maternal and Child Health and Family Planning Service Center,Anyi 330500,Jiangxi,China)
关键词:
乳酸菌阴道胶囊甲硝唑片阴道炎乳酸菌复发率
Keywords:
Lactobacillus vaginal capsuleMetronidazole tabletsVaginitisLactobacillusRecurrence rate
分类号:
R711.31
DOI:
10.3969/j.issn.1006-1959.2023.13.029
文献标志码:
A
摘要:
目的 探讨乳酸菌阴道胶囊联合甲硝唑片对阴道炎患者阴道乳酸菌恢复及复发的影响。方法 选取2018年5月-2022年3月在我院治疗的62例阴道炎患者为研究对象,采用随机数字表法分为对照组和观察组,各31例。对照组采用甲硝唑片治疗,观察组在对照组基础上给予乳酸菌阴道胶囊治疗,比较两组临床疗效、临床症状(白带异常、瘙痒)消失时间、乳酸杆菌恢复指标(乳酸杆菌阳性率、乳酸感杆菌阳性菌落>1/2检出率、产H2O2乳酸杆菌阳性率)、炎症因子[白细胞(WBC)、外周血嗜酸性粒细胞(EOS)计数、C-反应蛋白(CRP)]水平以及复发率。结果 观察组治疗总有效率为92.55%,高于对照组的80.65%(P<0.05);观察组白带异常、瘙痒症状消失时间均短于对照组(P<0.05);观察组乳酸杆菌阳性率、乳酸感杆菌阳性菌落>1/2检出率、产H2O2乳酸杆菌阳性率均高于对照组(P<0.05);两组治疗后WBC、EOS、CRP水平均低于治疗前,且观察组低于对照组(P<0.05);随访3个月,观察组复发率(6.45%)低于对照组(16.13%)(P<0.05)。结论 乳酸菌阴道胶囊联合甲硝唑片对阴道炎患者阴道乳酸菌恢复及复发均具有积极影响,可提高治疗效果,缩短症状消失时间,促进乳酸杆菌恢复,降低炎症因子水平和复发率,具有较高的有效性和安全性。
Abstract:
Objective To investigate the effect of lactobacillus vaginal capsule combined with metronidazole tablets on the recovery and recurrence of vaginal lactobacillus in patients with vaginitis.Methods A total of 62 patients with vaginitis treated in our hospital from May 2018 to March 2022 were selected as the research objects. They were divided into control group and observation group by random number table method, with 31 patients in each group. The control group was treated with metronidazole tablets, and the observation group was treated with lactobacillus vaginal capsule on the basis of the control group. The clinical efficacy, disappearance time of clinical symptoms (leucorrhea abnormality, pruritus), recovery index of lactic acid bacteria (positive rate of lactic acid bacteria, detection rate of lactic acid bacteria positive colony>1/2, positive rate of lactic acid bacteria producing H2O2), levels of inflammatory factors [white blood cell (WBC), peripheral blood eosinophil (EOS) count, C-reactive protein (CRP)] and recurrence rate were compared between the two groups.Results The total effective rate of treatment in the observation group was 92.55%, which was higher than 80.65% in the control group (P<0.05). The disappearance time of abnormal leucorrhea and pruritus in the observation group was shorter than that in the control group (P<0.05). The positive rate of lactic acid bacteria, the positive rate of lactic acid bacteria positive colony>1/2 and the positive rate of lactic acid bacteria producing H2O2 in the observation group were higher than those in the control group (P<0.05). The levels of WBC, EOS and CRP in the two groups after treatment were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). After 3 months of follow-up, the recurrence rate of the observation group (6.45%) was lower than that of the control group (16.13%) (P<0.05).Conclusion Lactobacillus vaginal capsule combined with metronidazole tablets has a positive effect on the recovery and recurrence of vaginal lactic acid bacteria in patients with vaginitis, which can improve the therapeutic effect, shorten the time of symptom disappearance, promote the recovery of lactic acid bacteria, reduce the level of inflammatory factors and recurrence rate, and has high efficacy and safety.

参考文献/References:

[1]孙虹,刘庆云.甲硝唑联合乳酸杆菌及雌三醇对老年阴道炎患者疗效及生活质量的影响[J].齐齐哈尔医学院学报,2019,40(17):2172-2173.[2]赵晴,赵仲华.甲硝唑对阴道炎患者阴道分泌物病原体分布的影响[J].中国临床药理学杂志,2020,36(17):2624-2626,2634. [3]苏艳莉.乳酸菌阴道胶囊在阴道炎治疗中的临床应用[J].中国卫生标准管理,2018,9(16):84-86.[4]任传伟,赵时梅.细菌性阴道炎合并妇科感染性疾病的临床特点[J].中国病原生物学杂志,2018,13(4):421-423.[5]中华医学会妇产科学分会感染性疾病协作组.阴道毛滴虫病诊治指南(2021修订版)[J].中华妇产科杂志,2021,56(1):7-10.[6]戴晓晓,杜珂珂,赵静,等.乳杆菌活菌胶囊联合抗生素治疗细菌性阴道炎的疗效及复发情况分析[J].中国妇幼保健,2020,35(11):108-110.[7]周仙园.乳酸菌阴道胶囊联合小剂量甲硝唑对中晚期妊娠滴虫性阴道炎妇女阴道菌群的调节作用[J].中国微生态学杂志,2018,30(1):90-92.[8]邓丽.阴道炎治疗中应用乳酸菌阴道胶囊的临床治疗效果研究[J].国际感染病学(电子版),2020,9(2):130.[9]Paladine HL,Desai UA.Vaginitis: diagnosis and treatment[J].American Family Physician,2018,97(5):321-329.[10]郭元元,杨双双.1830例女性阴道炎患者阴道微生态调查[J].中国微生态学杂志,2019,31(3):339-343.[11]孔林,隋龙,王玲君,等.乳酸菌对阴道炎患者阴道微环境的调节作用[J].中华医院感染学杂志,2016,26(22):5195-5198.[12]Rumyantseva TA,Bellen G,Savochkina YA,et al.Diagnosis of aerobic vaginitis by quantitative real-time PCR[J].Arch Gynecol Obstet,2016,294(1):109-114.[13]罗丽.乳酸菌阴道胶囊联合戊酸雌二醇治疗老年性阴道炎疗效观察[J].实用中西医结合临床,2017,1(11):34-36.[14]唐砚彩.红核妇洁洗液治疗细菌性阴道病及其对阴道微生态影响的研究[D].成都:成都中医药大学,2020.[15]孙瑾,宋筱.雌激素联合乳酸菌阴道胶囊治疗老年性阴道炎疗效观察[J].四川医学,2017,38(8):924-926.

相似文献/References:

[1]林 苗,余怡红,徐丽红.罗红霉素、保妇康栓联合乳酸菌阴道胶囊序贯治疗混合感染性阴道炎的临床疗效[J].医学信息,2022,35(20):124.[doi:10.3969/j.issn.1006-1959.2022.20.033]
 LIN Miao,YU Yi-hong,XU Li-hong.Clinical Efficacy of Roxithromycin, Baofukang Suppository Combined with Lactobacillus Vaginal Capsule in Sequential Treatment of Mixed Infectious Vaginitis[J].Journal of Medical Information,2022,35(13):124.[doi:10.3969/j.issn.1006-1959.2022.20.033]
[2]黎玲玲,王火琴,方春芳.辅助应用乳酸菌阴道胶囊治疗阴道炎的效果及对患者阴道微环境的调节作用[J].医学信息,2022,35(21):125.[doi:10.3969/j.issn.1006-1959.2022.21.032]
 LI Ling-ling,WANG Huo-qin,FANG Chun-fang.Effect of Adjuvant Application of Lactic Acid Bacteria Vaginal Capsules in the Treatment of Vaginitis and the Regulation of Vaginal Microenvironment in Patients[J].Journal of Medical Information,2022,35(13):125.[doi:10.3969/j.issn.1006-1959.2022.21.032]

更新日期/Last Update: 1900-01-01